Experiment 1010155

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationLEIMERT,JT: CORDER,MP: ELLIOTT,TE: LOVETT,JM:. (1980). AN ABBREVIATED PHASE II TRIAL OF THALICARPINE.. 64()
Amount utilized
Compound isolated
DiseaseA HASE II CLINICAL TRIAL INVOLVING 14 PREVIOUSLY TREATED PATIENTS WITH ADVANCES MALIGNANT DISEASE EACH PATIENT RECEIVED ONE TO EIGHT I.V. INFUSIONS THERE WERE NO COMPLETE OR PARTIAL OBJECTIVE RESPONSES. TOXIC EFFECTS INCLUDED NAUSEA(7 PATIENTS),VOMITING(3 PATIENTS),CARDIOVASCULAR EFFECTS(2 PATIENTS),ECG CHANGES(8 PATIENTS),ETC.
Dose amount1.1 GM
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES